WeVote
Log In

Bill

Bill

SB 748

Public Health - Alzheimer's Disease and Related Dementias - Information on Prevalence and Treatment

2025 Regular Session

Maryland requires its health department to publicly compile and distribute information on Alzheimer's disease prevalence and available treatments to improve patient access to care resources.

Approved by the Governor - Chapter 682
0
WeVote Research Nonpartisan
Bill Summary · SB 748

Legislative bill overview

SB 748 requires Maryland's Department of Health to compile and publish comprehensive information on the prevalence of Alzheimer's disease and related dementias (ADRD) in the state, along with available treatment options and clinical resources. The bill mandates that this information be made publicly accessible to help patients, families, and healthcare providers navigate available care options.

Why is this important

Maryland joins states recognizing that Alzheimer's and related dementias affect thousands of residents and families who often lack centralized, reliable information about prevalence rates and treatment pathways. By creating an official information repository, the state aims to improve early diagnosis rates, facilitate treatment decisions, and help families access appropriate resources during a critical health journey.

Potential points of contention

  • Resource allocation: Critics may question whether compiling this information requires significant state funding that could be directed toward direct patient care or research initiatives instead
  • Information accuracy and maintenance: Ensuring treatment information remains current as new therapies emerge requires ongoing state resources and coordination with providers
  • Limited scope: The bill focuses on information dissemination rather than expanding actual treatment access, funding, or research—some advocates may view this as insufficient action

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.